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Neurotrophins are growth factors of fundamental importance for the development,
survival and maintenance of different neuronal and non-neuronal populations. Over
the years, the use of labeled neurotrophins has helped in the study of their biological
functions, leading to a better understanding of the processes that regulate their
transport, traffic, and signaling. However, the diverse and heterogeneous neurotrophin
labeling strategies adopted so far have often led to poorly reproducible protocols
and sometimes conflicting conclusions. Here we present a robust, reliable, and fast
method to obtain homogeneous preparations of fluorescent proNGF and NGF with 1:1
labeling stoichiometry. This strategy is well suited for several applications, ranging from
advanced imaging techniques such as single particle tracking, to analyses that require
large amounts of neurotrophins such as in vivo monitoring of protein biodistribution.
As a proof of the quality of the labeled NGF and proNGF preparations, we provide
a quantitative analysis of their colocalization with proteins involved in the signaling
endosome function and sorting. This new analysis allowed demonstrating that proNGF
localizes at a sub-population of endosomes not completely overlapped to the one
hosting NGF.
Keywords: fluorescent NGF, fluorescent proNGF, neurotrophins labeling, neurotrophins purification, signaling
endosome
INTRODUCTION
Neurotrophins (NTs) exert a multitude of biological functions both in the central and peripheral
nervous system, related to neuronal development, adult physiology, and neurodegenerative
processes.
The use of labeled neurotrophins has represented, over the years, a valuable experimental
strategy to investigate NT functions. Several methods to chemically label NTs have been presented
in the literature, spanning from radioiodinated NGF (Frazier et al., 1974; Max et al., 1978) to
chemically-labeled NTs (Rosenberg et al., 1986; Bronfman et al., 2003; Shibata et al., 2006; Cui
et al., 2007; Echarte et al., 2007; Nomura et al., 2011). In all these methods, the chemical labeling
is not site-directed at defined residues of the NT molecule and the labeling stoichiometry is poorly
controlled. For intracellular imaging, NT-GFP fusions have been used (Mowla et al., 1999; Adachi
et al., 2005), but the large size of the GFP moiety is not ideal. All these neurotrophin labeling
methods often caused poorly reproducible results and sometimes inconsistent conclusions. Thus,
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there is a great need for a new generation of site-directed NT
labeling methods exploitable for a variety of applications.
Building on work by Sung et al. (2011), our group has recently
developed a new site-directed and stoichiometry-controlled
labeling of NGF and proNGF (Marchetti et al., 2014; De Nadai
et al., 2016). Accordingly, the coding sequence of human proNGF
can be modified by the C-terminal insertion of the YBBR tag
coding sequence (De Nadai et al., 2016). This 11-amino-acid
long peptide (DSLEFIASKLA) was identified from a series of
truncated proteins derived from the ybbR ORF gene of Bacillus
subtilis and shown to be an efficient substrate for the enzymatic
activity of the Sfp synthase enzyme (Yin et al., 2005). Once
translated, this tag is specifically recognized by this enzyme,
which covalently conjugates the phosphopantetheinyl arm of a
Coenzyme A (CoA) substrate to a specific serine in the YBBR
sequence (Yin et al., 2005). Thus, the use of fluorescent CoA
derivatives (e.g., CoA-Alexa647) allows to produce fluoNGF and
fluoproNGF (De Nadai et al., 2016). This labeling strategy has
several advantages: (i) it allows for the purification of fully
functional labeled precursor and mature neurotrophins; (ii) the
controlled, site-specific fluorolabeling allows the production of
homogeneously labeled NTs, suitable for quantitative analysis;
(iii) it is versatile, allowing to covalently conjugate different
derivatives of CoA, depending on the purpose.
This labeling strategy has allowed comparing, for the first
time, the transport properties of proNGF and NGF at the level
of single vesicles in living cells (De Nadai et al., 2016). Due to
the potential of this new NT labeling method, there is a big
interest to optimize the procedure and to facilitate the production
of fully validated labeled NTs. In this work we present an
optimized robust and reproducible protocol for the purification
of fluorescent NGF and proNGF (hereafter referred as fluoNGF
and fluoproNGF) with higher yield, specific activity, and purity
degree. Obtained fluoproNGF and fluoNGF were used in an
internalization assay in differentiated PC12 cells and probed for
their colocalization with proteins previously identified to regulate
the trafficking and sorting of NGF signaling endosomes, such as
Rab11, Rab7, Rab5, and EEA1 (Liu et al., 2007; Sorkin and von
Zastrow, 2009; Wu et al., 2009). Data show that the divergent
signaling promoted by these two NT forms relies also on distinct
internalization routes undertaken by the two of them.
MATERIALS AND METHODS
Protein Expression
All chemical reagents were purchased from Sigma-Aldrich. The
plasmid containing the sequence for the recombinant expression
of the human proNGF-YBBR has been previously obtained by the
insertion of the YBBR coding sequence downstream the sequence
encoding for proNGF (De Nadai et al., 2016). Escherichia coli
BL21 strain was transformed with 100 ng of plasmid. The cells
were plated onto a petri dish containing Luria Bertani (LB)
medium supplemented with agar and ampicillin, and grown
overnight at 37◦C.
The day after, one colony was picked and inoculated in 20
ml of LB medium supplemented with ampicillin and grown
overnight at 37◦C with shaking at 250 rpm. Then, 18 ml of this
culture were inoculated in 1 L of LB medium supplemented with
ampicillin, splitted into five flasks each containing 200 ml and
allowed to grow until an OD600 of about 1 was reached, before
inducing protein expression with 1 mM of IPTG (Isopropil-β-D-
1-tiogalattopiranoside) for 5 h at 37◦C.
Purification of Inclusion Bodies
Expressing bacteria were centrifuged at 6000 rpm, 4◦C for 10
min. The obtained pellets were resuspended in 20 ml of lysis
buffer (10 mM Tris-HCl pH 8; 1 mM EDTA pH 8, and 1 mg/ml
lysozyme) and allowed to stand for 1 h at room temperature.
This solution was sonicated three times (45′′ ON, 60′′ OFF at
4◦C) and finally DNAse (50 µg/ml) supplemented by MgCl2 (5
mM) was added. After 30 min, 10 ml of Triton buffer was added,
consisting of 60 mM EDTA, 1.5 M NaCl, and 6% v/v TRITON
X-100 (Sigma-Aldrich).
After 30 min of gentle shaking, the solution was transferred
into two glass centrifuge tube (Corex) and centrifuged at 13,000
rpm, 4◦C for 30 min. The supernatant was discarded, and the
pellet was resuspended in 20 ml of buffer containing: 10 mM
Tris-HCl pH 8 and 1 mM EDTA. At this point 10 ml of Triton
buffer was added to the solution, incubated for 30 min in gentle
shaking, finally followed by centrifugation at 13,000 rpm, 4◦C for
30 min. The pellet was washed three times using 25 ml of buffer
containing: 50 mM Tris-HCl pH 7.5 and 1 mM EDTA, adopting
for each step the previously mentioned centrifugation settings.
Protein Refolding
To allow the proper denaturation of the neurotrophin, the
obtained pellet was solubilized in 5 ml of Guanidinium buffer (6
M Guanidinium chloride; 100 mM TrisHCl pH 8; 1mM EDTA;
100 mMDithiothreitol). Then hydrochloric acid was added until
the solution reached pH 3.5. At this point the solution was
centrifuged at 13,000 rpm, 4◦C for 30 min. The supernatant,
containing the protein of interest, was dialyzed in 300 ml of 6
M Guanidinium chloride pH 3.5 for 36 h, changing the buffer
every 12 h.
After dialysis, the protein concentration was measured and
5mg of neurotrophin was added every hour to 100ml of refolding
buffer (1 M Arginine pH 9.3; 100 mM Tris-HCl pH 9.3; 5 mM
EDTA pH 8; 1 mM Glutathione disulphide and 5 mM reduced
Glutathione) at 4◦C. After completing the refolding step, the
buffer was exchanged by dialysis with one containing 50 mM
sodium phosphate buffer pH 7 and 1 mM EDTA. After overnight
dialysis, the solution was centrifuged at 7500 rpm for 5 min and
then filtered (0.22 micron pore size).
Neurotrophins Purification
To obtain a pure solution of proNGF-YBBR, the refolded
neurotrophin was purified by ion-exchange FPLC, using
HiLoadTM 16/10 SP SepharoseTM High Performance column (GE
Healthcare Life Sciences) and the following mobile phase buffer:
50 mM sodium phosphate buffer pH 7; 1 mM EDTA with 0
M or 1 M NaCl respectively in buffer A or buffer B. A linear
gradient from 0 to 100% of buffer B in eight column volumes
was applied to elute the protein, at 1 ml/min of flow rate.
Fractions of 3 ml were collected. A small aliquot (20 µl) of
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each fraction was assayed by SDS-PAGE. Fractions containing
the protein were pooled obtaining about 18mg of proNGF-
YBBR at a final concentration of 1 mg/ml. Four milligrams
of protein were dialyzed overnight in a buffer containing 50
mM sodium phosphate buffer pH 7 and 150 mM NaCl (storage
buffer), and finally aliquoted. To ascertain the integrity of the
purified neurotrophin, 100 µg of protein was analyzed by mass
spectrometry (MS). MS analysis was performed by an external
facility (Toscana Life Sciences Foundation).
Mature neurotrophin was obtained by controlled proteolysis
of the purified proNGF-YBBR, using trypsin protease (1 µg
of enzyme for 300 µg of neurotrophin, 16 h at 4◦C). 14 ml
of solution containing proNGF-YBBR was digested and then
diluted in 100 ml of FPLC buffer A. Another step of FPLC
chromatography was used for the purification of mature NGF-
YBBR; three peaks were found in the chromatogram. Twenty
microliters of each collected fraction were analyzed by SDS-
PAGE in this case as well. Small amounts (100 µg each) from
three different fractions (32, 45, 58 as in Figure 2) were analyzed
by MS. The obtained fractions of NGF-YBBR were pooled in this
way: from fraction 32 to 39 (1◦ peak), from 42 to 50 (2◦ peak),
and from 52 to 62 (3◦ peak). The three samples were dialyzed
overnight in the storage buffer and separately aliquoted. The
stability of the YBBR proNGF and NGF proteins upon storage
at−80◦C and at a concentration of 1 mg/ml was found not to be
qualitatively different from that of their wild type counterparts.
fluoproNGF and fluoNGF Production
CoA-Alexa647 substrate was synthesized starting from 200 nmol
of Alexa647 maleimide (Thermo Fisher Scientific) and 260 nmol
of CoA trilithium salt (Sigma Aldrich) dissolved in 20 mM
HEPES pH 7.2 up to a final volume of 240 µl. The solution was
incubated for 4 h at 350 rpm and 37◦C, and it was then purified
by Reverse Phase HPLC using Phenomenex Fusion-RP phase
column and 10 mM ammonium formate/acetonitrile as mobile
phase. The purified adduct was quantified, lyophilized in ≈50
nmol aliquots, resuspended in H2O and stored at −20
◦C. Sfp
Synthase was either produced in E. coli as a His-tagged protein
as previously described (Yin et al., 2006), or purchased at New
England Biolabs (NEB).
For the fluorolabeling reaction of proNGF-YBBR, 85 µg of
neurotrophin were incubated for 30 min at 37◦C and 350 rpm
in a reaction mix composed by: 76 µM CoA-Alexa647, 4.8 µM
Sfp Synthase (NEB), 38 mMMgCl2, in phosphate buffer (#D8662
Sigma Aldrich) up to 260 µl final volume. For the fluorolabeling
of NGF-YBBR, 90µg of neurotrophin were incubated in the same
conditions of the proNGF-YBBR in buffer containing: 73 µM
CoA-Alexa647, 17µMSfp Synthase, 36mMMgCl2, in phosphate
buffer up to 270 µl final volume.
We found that performing the labeling reaction in the same
tubes used to store the aliquots of the neurotrophin is critical in
order to avoid massive loss of protein. After adding phosphate
buffer, the reaction tube was spun at 7000 rpm for 1 min at 4◦C.
Then the remaining reagents were added. After the reaction was
complete, the reaction tube was immediately placed on ice.
In order to separate the fluorescent neurotrophins from
the non-reacted ones, the reaction mix was processed by
cation-exchange HPLC, keeping the temperature of the sample at
4◦C after the chromatographic run, using Propac SCX-20 column
(Dionex, Thermo Fisher Scientific) and 100 mM HNa2PO4
mobile phase with 0 M to 1 M NaCl gradient. The fluorescent
proNGF and NGF proteins were stored at 4◦C at a concentration
of about 4 and 14 µg/ml, respectively, and were found to be
stable, as fluorescent proteins, for 15–20 days.
Immunocytochemistry
PC12 cells (ATCC, CRL-1721) were maintained at 37◦C, 5% CO2
in RPMI 1640 GlutaMAX medium (Thermo Fisher Scientific)
supplemented with 10% horse serum, 5% fetal bovine serum,
and 1% penicillin/streptomycin from Gibco (complete medium).
Cells were first primed for differentiation, i.e., maintained at
50–70% confluency in complete medium supplemented with 15
ng/ml of wt recombinant human NGF for 6 days, with 70% of the
medium renewed every 2 days.
After 6 days of priming, cells were harvested and the
medium completely replaced with RPMI 1640 GlutaMAX
supplemented with 1% horse serum, 0.5% fetal bovine serum,
1% penicillin/streptomycin, and 50 ng/ml of wt recombinant
humanNGF (differentiationmedium). Cells were plated on Poly-
L-lysine coated 8 well Glass micro-Slide (Ibidi) microscope slides,
at 20,000 cells/cm2 density. All medium was renewed every 48 h.
Four days of differentiation are necessary to complete the process.
At the end of the differentiation process, mediumwas replaced
with sterile phosphate buffer with Calcium and Magnesium
(#D8662 Sigma Aldrich) in order to wash out residual NGF
traces. After 1 h, the medium was replaced with differentiation
medium containing fluoproNGF (200 ng/ml) or fluoNGF (100
ng/ml). After 3 h of incubation with each fluoNT, cells were fixed
using 4% paraformaldehyde and 4% sucrose in phosphate buffer
for 15 min. Cells were then permeabilized in phosphate buffer
containing 8% of Bovine Serum Albumin (Sigma Aldrich) and
0.1% Saponin (Sigma Aldrich) for 7 min. After five washes in
phosphate buffer supplemented with 8% BSA, cells were blocked
using the same solution for 1 h. The primary antibodies (Anti-
Rab11 Cell Signaling #5589, 1:200; Anti-Rab7 Cell Signaling
#9367, 1:200; Anti-Rab5 Cell Signaling #3547, 1:300; Anti-
EEA1 Cell Signaling #3288, 1:200) were administered for 16 h
at 4◦C, diluted in blocking solution. The secondary antibody
(Anti-Rabbit conjugated to Alexa488 fluorophore, 1:500, Life
Technologies) was administered for 2 h at room temperature.
The cells were washed three times with phosphate buffer and
once with Milli-Q water (Millipore), dried and maintained in
mounting medium (Fluoroshield, Sigma).
Microscopy Measurements
Images were captured using a confocal laser scanningmicroscope
(Leica TCS SP5 SMD), equipped with 63X/1.2 NA objective.
0.7 airy unit pinhole was adopted. Fluorescence signals were
acquired using Ar 488 and 633 solid state lasers sequentially.
PMT detection bandwidths were 503–570 nm for Alexa488
and 645–767 nm for Alexa647. The images were acquired by
maintaining a pixel size of ∼90 nm and an image dimension
of 512 × 512 pixels. About 20 cells were analyzed for each
experimental condition.
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Image Analysis
Colocalization analysis was performed by custom made Matlab
scripts. Images were subjected to pixelwise adaptive Wiener
filtering for noise removal (Matlab function wiener2; estimation
of mean, standard deviation, and noise power in a 15-by-
15 pixels window), local background subtraction (Gaussian
blurring with a 15-pixels- wide Gaussian kernel), and Gaussian
smoothing (3 pixels). Colocalization was quantified using a
Manders colocalization coefficient (Dunn et al., 2011), with
thresholds set at 10% of the maximum in the single image. The
script returns the percentage of NT’s fluorescence signal that
colocalizes with the signal of the considered protein partner,
among the total neurotrophin signal.
Statistical Analysis
Statistical analysis of data was performed using OriginLab
software. The differences in the colocalization percentage
between NGF and proNGF with endosomal partners were
analyzed by two-tailed Student’s t-test. For all the analyses α =
0.05 was adopted as a level of significance.
RESULTS
proNGF-YBBR and NGF-YBBR Expression
and Purification
As we previously demonstrated (De Nadai et al., 2016), proNGF-
YBBR can be produced in E. coli and collected from inclusion
bodies, similarly to what already reported for the wt, untagged
neurotrophin (Rattenholl et al., 2001; Paoletti et al., 2011). Once
extracted in denaturing conditions, the tagged neurotrophin is
refolded and further purified by ion-exchange FPLC in order
to obtain a pure solution of proNGF-YBBR. As indicated in
Figure 1, fractions corresponding to the protein elution peak
typically contain ≈20mg of almost pure protein per liter
of culture. Mass spectrometry analysis of the same fractions
demonstrates that they indeed correspond to the full-length
protein (Figure 1C).
To obtain the mature tagged neurotrophin, controlled
proteolysis of the purified proNGF-YBBR is performed with
trypsin protease. Another step of FPLC chromatography is used
for the purification of mature NGF-YBBR. As indicated in
Figure 2, the chromatographic run of NGF-YBBR reveals the
presence of at least three different species having slightly different
elution times. These data suggest that different digestion products
arise upon trypsin cleavage. This prompted us to analyze by
mass spectrometry (MS) aliquots from the three fractions, which
allowed identifying the presence of at least 3, 2, and 4 digestion
products, respectively in the first, second and third elution peaks.
These correspond to 5 differentmolecular species (some populate
more than one peak), which are fully listed inTable 1; all detected
trypsin cleavage sites are highlighted in Figure 2C.
fluoproNGF and fluoNGF Production
Once the proNGF-YBBR and NGF-YBBR are purified, these can
be used in a labeling reaction to covalently conjugate in vitro
each neurotrophin monomer to a single Alexa647 fluorophore
(Figure 3A). After the labeling reaction, the fluorescent precursor
FIGURE 1 | proNGF-YBBR purification. (A) Chromatographic profile of
FPLC analysis. Black line and blue line represents respectively the absorbance
at 280 nm and the percentage of buffer B on the total flowing buffer. The
numbers identifying the collected fractions are shown in red. (B) SDS-PAGE
analysis of the collected fractions corresponding to the proNGF-YBBR peak.
On the left side of the gel, molecular standard weights (kDa) are shown.
Numbers of each lane correspond to the fraction analyzed. (C) MS analysis of
the protein has revealed the presence of a unique species, corresponding to
the full-length proNGF-YBBR.
and mature neurotrophins are processed by ion exchange HPLC
to separate the labeled neurotrophins from both the non-reacted
ones and the free fluorophores. As for proNGF, the fluorolabeled
species can be readily identified (Figure 3C), exploiting the
fact that the negative charge of the Alexa647 produces a shift
toward a lower retention time in the column. As for NGF-
YBBR, optimization of the labeling reaction was required, given
that the presence of different but similar digestion products
(Figure 2) could lead to a mixture of fluorolabeled functional
proteins with undesired not-fluorolabeled species or with poorly-
functional ones (Table 1). As the MS analysis performed does
not give robust information about the relative abundance of each
digestion species, in order to have a better understanding of
the protein composition of each of the elution peaks of NGF-
YBBR purification, we first run individually the three of them
through an ion-exchange HPLC column. Figure 3 outlines the
presence of one main species for each fraction. These species are
likely different in the three cases as they have a retention time of
about 11.8, 14.8, and 18.5 min, respectively. The three fractions
were then subjected to the fluorolabeling reaction. We observed
a shift of the retention time in column (i.e., the appearance
of a fluorolabeled specie) for the first (2.7 min, Figure 3B,
upper right graph) and the second (8.9 min, Figure 3B, middle
right graph), but not for the third peak (Figure 3B, lower
right graph). According to the MS analysis and to the relative
predicted isoelectric points, themain species of the first two peaks
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FIGURE 2 | NGF-YBBR purification and characterization. (A) Chromatographic profile of FPLC analysis. Black line and blue line represents respectively the
absorbance at 280 nm and the percentage of buffer B on the total flowing buffer. Numbers in red identify the fractions used for the MS analysis. (B) MS analysis of
fractions 32, 45, and 58 has revealed the presence of respectively 3, 2, and 4 different digestion products. (C) Schematic illustration of the proNGF-YBBR. The amino
acid sequence is highlighted and the proteolytic cleavage sites are identified by the triangles. The color code of the triangles that identify the different NGF species are
also reported in Table 1.
TABLE 1 | The table illustrates the various trypsin digestion products.
Name of the specie MW (Da) pI Cleavage site Description of the digestion product Tag
desoctaNGF−YBBR-2 C-Term 13202.8 8.27 R +9; L +128 Without the first 9 aa at the N-terminus and 2 aa at the C-terminus Yes
NGF−YBBR -2 C-Term 14252.6 8.56 R −1; L +128 Without 2 aa at the C-terminus Yes
NGF−Tag YBBR 13261.3 8.81 R −1; R +118 Without 11 aa at the C-terminus No
NGF−YBBR +R N-Term; -2 C-Term 14408.4 8.8 K −2; L +128 Plus the arginine at the N-terminus and without 2 aa at the C-terminus Yes
NGF+R N-Term -Tag YBBR 13417.1 9.0 K −2; R +118 Plus the arginine at the N-terminus and without 11 aa at the C-terminus No
The first reported specie, lacking the first 9 amino acids, is here termed “DesoctaNGF” because it resembles the naturally occurring desocta form reported for murine NGF (Fahnestock,
1991). The other species are characterized by the lack of two amino acids or of the entire YBBR tag at the C-terminus (-2 C-Term or -Tag YBBR). The species that contains the arginine
at the N-Terminus are also shown (+R N-Term). The second and third columns show the molecular weights (Dalton) and the theoretical isoelectric point of the digested species. The
amino acids numeration adopted is in accordance to the literature (Paoletti et al., 2009).
correspond to desoctaNGF-YBBR -2 C-Term and NGF-YBBR -
2 C-Term. Instead, the third fraction likely represents NGF +R
N-Term -Tag YBBR as the main species. Given the lack of the
YBBR tag, this specie preserves an unaltered retention time after
the labeling reaction. Overall, these experiments demonstrated
that the second peak of NGF-YBBR FPLC purification was the
most suited to be subsequently fluorolabeled. In any case, the
additional post-labeling HPLC run is recommended to separate
the labeled functional protein from the other resulting from the
whole process, which create smaller but non-negligible peaks
in the chromatogram as shown in the middle-right panel of
Figure 2B.
This protocol allowed us to obtain ∼6.3 µg of fluoproNGF
and 21.1 µg of fluoNGF, starting respectively from 85 to 90
µg of proNGF-YBBR and NGF-YBBR, a yield of 7.4 and 23.4%
respectively. A summary of the whole purification process, with
the different yields obtained at every separate step, is reported in
Table 2.
Endosomal Localization Analysis of
fluoproNGF and fluoNGF
As a proof of the quality of our fluorolabeled preparations,
fluoproNGF and fluoNGF were individually administered within
a 3 h interval to differentiated PC12 cells, aiming at characterizing
their relative association with endosomal partners involved in
their internalization. In detail, we carried out a colocalization
analysis of both NGF and proNGF with Rab11, Rab7, Rab5,
and EEA1. These proteins have been previously reported to
crucially regulate the maintenance/quenching and balance of
trophic support during neurotrophin signaling (Saxena et al.,
2005; Liu et al., 2007).
As shown in Figure 4, first of all we found that endosomes
containing NGF have a higher intensity of fluorescence,
compared to proNGF ones. This fact is in agreement with our
previous observations that a different average number of NTs
dimers is contained per endosome in the two cases (De Nadai
et al., 2016). Furthermore, we found that proNGF endosomes
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FIGURE 3 | Labeling strategy and fluoNTs HPLC purification. (A) Schematic representation of the labeling strategy. Structure of NGF dimer is shown (figure
taken from PDB: 1BTG and adapted using UCSF Chimera). The YBBR tag is schematized as an alpha helix and depicted in yellow, side chain of the serine involved in
the labeling reaction is also shown. (B) Chromatographic profile of the first (top), second (middle), and third (bottom) NGF-YBBR fractions. 18.75 µg of tagged NT
were run without performing the labeling reaction. The black line represents the absorbance at 280 nm. The chromatographic profiles of the first, second and third
NGF-YBBR fractions after the labeling reaction are also shown, on the right of the respective non-labeled counterparts. Also in this case, 18.75 µg of tagged NT were
used for the labeling reaction. Black and red lines represent the absorbance at 280 nm and 650 nm, respectively. (C) Superimposed HPLC chromatographic profiles
of fluoproNGF and proNGF-YBBR. In all chromatograms, the first peak with about 1 min of retention time is caused by unreacted free fluorophore. The unreacted
proNGF-YBBR or NGF-YBBR are virtually undetectable.
TABLE 2 | fluoproNGF and fluoNGF purification yields.
Neurotrophin Step 1: FPLC purification to obtain NT-YBBR Step 2: HPLC purification to obtain fluoNT
proNGF 18 mg per liter of E. coli colture (4mg are stored) From 85 µg: 6.3 µg
NGF ∼3.5mg per 14mg of proNGF-YBBR used in the tryptic digestion From 90 µg: 21.1 µg
1◦ elution peak 2◦ elution peak 3◦ elution peak
1 mg 1.5 mg 0.8 mg
Yields obtained at each step of the whole process are reported. In particular, the E. coli expression system typically provides 18mg of proNGF-YBBR per colture liter after the first
purification step. Of these, 4mg can be stored and 14mg are used for the production of NGF-YBBR after the trypsin digestion. 3.3mg of NGF-YBBR are typically obtained, resulting
as the combination of 5 different digestion products eluted at three different peaks (see Table 1). In the second step, aliquots of 85 or 90 µg were used to perform the fluoroabeling
reaction. After the final HPLC purification, 6.3 or 21.1 µg of pure fluoproNGF or fluoNGF, respectively, can be obtained.
are almost never detectable in neurites of PC12 cells, contrary
to what seen for NGF ones (Supplementary Figure 1). These
observations prompted us to develop a colocalization algorithm
independent from absolute fluorescence intensity (see Section
Materials and Methods) and to restrict our analysis to PC12
soma regions. Our data revealed that the average percentage of
colocalization calculated for proNGF with all four endosomal
partner considered is significantly different from that observed
for NGF. This result will be discussed in light of the opposite
biological functions displayed by precursor NGF with respect to
the mature form.
DISCUSSION
The lack of a standardized protocol for the production and
purification of fluorolabeled neurotrophins has led to the
development of amultitude of different strategies for this purpose
(Marchetti et al., 2015; De Nadai et al., 2016). The chemical
conjugation of organic dyes to NTs amino- or carboxy- residues
(Rosenberg et al., 1986) is maybe the most straightforward
of these approaches, but suffers of poor reproducibility. NT
chemical biotinylation and further conjugation to Qdot is so far
the most used approach (Cui et al., 2007; Wong et al., 2015).
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FIGURE 4 | Colocalization analysis. PC12 cells imaged by confocal microscopy. Immunocytochemistry experiment showing the colocalization of fluoproNGF or
fluoNGF with the endosomal protein partners. Scale bar is 5 µm. On the right of each panel the quantitative analysis of the colocalization of fluoproNGF or fluoNGF
with endosomal partners Rab11, Rab7, Rab5, and EEA1 is shown. The histograms show the average colocalization percentage. The color code used is light gray for
proNGF and dark gray for NGF. The error bars represent the standard error of the mean and p is the p-value.
However, the vast majority of these approaches does not allow a
controlled stoichiometry of labeling, leading to the production of
heterogeneously labeled species. Moreover, despite their excellent
optical properties, Qdot particles generally have a cumbersome
size usually no less than 10 nm in diameter. These aspects are
particularly relevant in the neurotrophin-signaling system, which
involves the axonal transport of small endosomes containing
a limited number of NT dimers, so that even small changes
in the number of carried NTs could reasonably lead to drastic
alterations in the downstream signaling (De Nadai et al., 2016).
Additionally, the presence of a big cargo such as Qdot or the non-
homogeneous NTs population could hinder the correct analysis
of the intracellular trafficking properties of these proteins, or
prevent the study of the dynamics of binding with the cognate
receptors.
Our labeling strategy overcomes many of the above-
mentioned limitations. In terms of absolute yield, the insertion
of the YBBR tag sequence does not affect the protein expression
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compared to the wt neurotrophin. In fact, 15–20mg of proNGF-
YBBR can be typically obtained per liter of bacterial culture, and
this quantity is totally equivalent to the wt, untagged proNGF
average yield. Importantly, this yield is also about tenfold higher
than typical yields obtained for mono-biotinylatable proNGF-
AVItag construct expressed in eukaryotic cells and purified from
the cell medium (Sung et al., 2011), which is of 1–1.2mg/L.
In this paper we characterized the heterogeneous population
constituting the mature NGF-YBBR protein used for labeling
and designed a procedure to get only the correct fluorolabeled
specie. Surprisingly, we found that although the correct NGF
species obtained lacks the last two aminoacids of the YBBR
tag, this can be still efficiently fluorolabeled by the Sfp enzyme;
thus, this will allow the use of a shorter and thus less invasive
YBBR tag for future studies. The use of negatively charged
fluorophores like Alexa647 in the labeling reaction and the
subsequent ion-exchange HPLC purification allow obtaining
a pure and homogeneous fluoproNGF and fluoNGF protein
population, which is fundamental in order to have a precise
control on the cellular response. The optimized method ensures
therefore a greater homogeneity and a higher specific activity of
the labeled NGF species.
Given the high absolute yield and the great purity grade
obtained, this strategy is well suited for several experimental
investigations, spanning from single molecule imaging analysis
on compartmentalized neuronal cultures (De Nadai et al., 2016),
to applications that require large amounts of homogeneous
neurotrophin preparations.
Our novel tool was here used to perform a quantitative
analysis of the colocalization of the two NGF forms with different
endosomal protein partners. It is known that neurotrophins
travel inside neurons in signaling endosomes characterized
by the presence of different Rab proteins (Matusica and
Coulson, 2014). The switching of these endosomal proteins
is implicated in the maintenance/quenching of neurotrophins
signaling (Saxena et al., 2005; Deinhardt et al., 2006; Liu et al.,
2007). Given the opposite biological functions displayed by
the mature and precursor forms of NGF, it seems reasonable
to hypothesize that these may originate by sub-populations of
signaling endosomes having distinct intracellular distributions
and sorting, finally leading to stronger (NGF) or weaker
(proNGF) trophic actions. Such a finding might be relevant,
e.g., for mechanisms linking proNGF/NGF unbalance and
neurodegenerative processes relevant for Alzheimer’s disease
(Tiveron et al., 2013).
The observation that proNGF endosomes are exclusively
found in the PC12 soma, contrary to NGF endosomes that
are also found in neurites, confirms that the cell biology of
the two neurotrophin forms is very different, as previously
observed in DRG neurons (De Nadai et al., 2016). Interestingly
however, in DRG neurons the proNGF is internalized at the
axon tips (from where it is transported to the soma), while it is
internalized at the soma level but not anterogradely transported.
It remains to be seen whether the transport properties of proNGF
and NGF are also different in PC12 cells. In any case, the
different internalization pattern in PC12 and DRG neurons
might be ascribed to the fact that PC12 neurite processes are
not differentiated in axons or dendrites and thus might be
functionally different from the fully polarized processes of DRG
neurons.
The analysis of the colocalization between the two fluorescent-
NTs and the endosomal protein partners did not highlight a
preference in the association of proNGF with any of the protein
partners considered. The average colocalization percentage of
proNGF was found to be about half of that seen for NGF for all
protein partners investigated. Although, many other Rab family
members were not considered in this work, our data suggest
that proNGF could undergo a different intracellular trafficking
compared to that of NGF. In particular, the anti-Rab5 antibody
used in this work recognizes specifically one isoform (A) out of
three (A, B, C). These endosomal proteins are considered master
regulators of the formation and sorting of early endosome; it
was observed that Rab5A and Rab5B are directly involved in the
trafficking of the epidermal growth factor receptor (a prototype
tyrosine kinase receptor), while Rab5C have a compensatory
function (Chen et al., 2009). Therefore, we cannot exclude that
proNGF could associate with other Rab5 isoforms involved
in compensatory functions with respect to those afforded by
Rab5A/NGF positive endosomes.
Further work will be necessary for the complete
characterization of the molecular composition of the signaling
endosomes populated by proNGF or NGF. The versatility of
the labeling strategy presented in this work could represent
a powerful tool to achieve this goal. For example, each
neurotrophin could be in principle also biotinylated and further
conjugated to streptavidin-coated magnetic nanoparticles, in
order to purify and analyze the respective signaling endosomes.
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